Viemed Healthcare Enters New Credit Agreement
Ticker: VMD · Form: 8-K · Filed: May 29, 2024 · CIK: 1729149
| Field | Detail |
|---|---|
| Company | Viemed Healthcare, Inc. (VMD) |
| Form Type | 8-K |
| Filed Date | May 29, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: debt, financing
TL;DR
Viemed Healthcare just signed a new credit deal, locking in financial obligations.
AI Summary
On May 28, 2024, Viemed Healthcare, Inc. entered into a material definitive agreement, specifically a credit agreement, which creates a direct financial obligation for the company. This agreement is a significant event for Viemed Healthcare, Inc. as it involves financial commitments and obligations.
Why It Matters
This filing indicates Viemed Healthcare, Inc. has secured new financing or restructured existing debt, which could impact its financial flexibility and operational capacity.
Risk Assessment
Risk Level: medium — Entering into new financial obligations can introduce risks related to debt servicing, interest rate fluctuations, and covenants.
Key Players & Entities
- VIEMED HEALTHCARE, INC. (company) — Registrant
- May 28, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Viemed Healthcare, Inc. on May 28, 2024?
The filing indicates the agreement is a credit agreement, creating a direct financial obligation for the registrant.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 28, 2024.
What is the principal executive office address for Viemed Healthcare, Inc.?
The principal executive office is located at 625 E. Kaliste Saloom Rd., Lafayette, Louisiana 70508.
What is the telephone number for Viemed Healthcare, Inc.?
The registrant's telephone number is (337) 504-3802.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 711 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-05-29 17:11:33
Filing Documents
- vmd-20240528.htm (8-K) — 35KB
- ex101052824.htm (EX-10.1) — 3KB
- creditagreementfirstamendmg.jpg (GRAPHIC) — 28KB
- creditagreementfirstamendmh.jpg (GRAPHIC) — 28KB
- creditagreementfirstamendmi.jpg (GRAPHIC) — 760KB
- creditagreementfirstamendmj.jpg (GRAPHIC) — 184KB
- creditagreementfirstamendmk.jpg (GRAPHIC) — 176KB
- creditagreementfirstamendml.jpg (GRAPHIC) — 79KB
- creditagreementfirstamendmm.jpg (GRAPHIC) — 44KB
- 0001729149-24-000148.txt ( ) — 1807KB
- vmd-20240528.xsd (EX-101.SCH) — 2KB
- vmd-20240528_lab.xml (EX-101.LAB) — 21KB
- vmd-20240528_pre.xml (EX-101.PRE) — 12KB
- vmd-20240528_htm.xml (XML) — 3KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. On May 28, 2024 , Viemed, Inc. (the " Borrower "), and certain subsidiaries of the Borrower, as guarantors (the " Guarantors "), all of which are wholly-owned subsidiaries of Viemed Healthcare, Inc. (the " Company "), entered into a First Amendment (the " First Amendment ") to the Credit Agreement dated as of November 29, 2022 (the " Credit Agreement ") by and among the Borrower, the Guarantors, Regions Bank, as administrative agent and collateral agent, and the other lenders party thereto. Pursuant to the First Amendment, the Credit Agreement was amended to (a) extend the Borrower's delayed draw term loan commitment expiration date to November 29, 2025, from its initial expiration date of May 29, 2024, and (b) provide for other technical amendments. The foregoing description of the First Amendment and the Credit Agreement is qualified in its entirety by reference to the First Amendment and the Credit Agreement, copies of which are attached hereto as Exhibits 10.1 and 10.2, respectively, and incorporated by reference herein. Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided under Item 1.01 of this Current Report on Form 8-K regarding the First Amendment is also responsive to Item 2.03 of this Current Report on Form 8-K and is hereby incorporated by reference into this Item 2.03.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 10.1 First Amendment to Credit Agreement dated November 29, 2022, among Viemed Inc. as borrower, certain subsidiaries of Viemed, Inc., as guarantors, the lenders from time to time party thereto, and Regions Bank, as administrative agent and collateral agent, effective May 28, 2024. 10.2 Credit Agreement, dated November 29, 2022, among Viemed, Inc., as borrower, certain subsidiaries of Viemed, Inc., as guarantors, the lenders from time to time party thereto, and Regions Bank, as administrative agent and collateral agent. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on November 29, 2022. 104 Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 29, 2024 VIEMED HEALTHCARE, INC. By: /s/ Trae Fitzgerald Trae Fitzgerald Chief Financial Officer